Somatic mutations of mitochondrial genome in hepatocellular carcinoma.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 20006738)

Published in Mitochondrion on December 16, 2009

Authors

Pen-Hui Yin1, Cheng-Chung Wu, Jin-Ching Lin, Chin-Wen Chi, Yau-Huei Wei, Hsin-Chen Lee

Author Affiliations

1: Department of Medical Research and Education, Taipei Veterans General Hospital, Taiwan, ROC.

Articles citing this

Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A (2012) 1.63

Somatic mutations in the D-loop of mitochondrial DNA in oral squamous cell carcinoma. Eur Arch Otorhinolaryngol (2011) 0.96

Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors. BMC Cancer (2012) 0.96

Dysfunctional mitochondrial bioenergetics and the pathogenesis of hepatic disorders. Front Cell Dev Biol (2015) 0.96

Mitochondrial DNA alterations and mitochondrial dysfunction in the progression of hepatocellular carcinoma. World J Gastroenterol (2013) 0.95

Mitochondrial DNA mutations and breast tumorigenesis. Biochim Biophys Acta (2013) 0.87

Somatic alterations in mitochondrial DNA and mitochondrial dysfunction in gastric cancer progression. World J Gastroenterol (2014) 0.82

Complex IV subunit 1 defect predicts postoperative survival in hepatocellular carcinoma. Oncol Lett (2014) 0.78

A Comprehensive Characterization of Mitochondrial Genome in Papillary Thyroid Cancer. Int J Mol Sci (2016) 0.77

Impact of somatic mutations in the D-loop of mitochondrial DNA on the survival of oral squamous cell carcinoma patients. PLoS One (2015) 0.77

Role of mitochondrial dysfunction in cancer progression. Exp Biol Med (Maywood) (2016) 0.77

Decoding Warburg's hypothesis: tumor-related mutations in the mitochondrial respiratory chain. Oncotarget (2015) 0.76

Associations between sequence variations in the mitochondrial DNA D-loop region and outcome of hepatocellular carcinoma. Oncol Lett (2016) 0.76

Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3. Int J Mol Sci (2016) 0.75

Aspartate β-hydroxylase disrupts mitochondrial DNA stability and function in hepatocellular carcinoma. Oncogenesis (2017) 0.75

Articles by these authors

Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med (2004) 3.19

Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol (2005) 2.91

Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res (2003) 2.70

Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells (2008) 2.34

Attenuation of oxidative stress after varicocelectomy in subfertile patients with varicocele. J Urol (2007) 2.20

The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett (2004) 2.15

miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res (2008) 2.09

Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res (2004) 2.01

Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer (2005) 1.99

Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci (2005) 1.97

Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med (Maywood) (2002) 1.96

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: a randomized phase II trial for safety and optimal dosage. J Hepatol (2009) 1.82

Prognostic variables in thoracic esophageal squamous cell carcinoma. Ann Thorac Surg (2009) 1.81

Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer (2006) 1.77

Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res (2007) 1.73

The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res (2009) 1.62

Cisd2 deficiency drives premature aging and causes mitochondria-mediated defects in mice. Genes Dev (2009) 1.61

Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis. J Clin Gastroenterol (2007) 1.60

Definitive intensity-modulated radiation therapy with concurrent chemotherapy for patients with locally advanced cervical cancer. Gynecol Oncol (2011) 1.57

Is the corrected-creatinine model for end-stage liver disease a feasible strategy to adjust gender difference in organ allocation for liver transplantation? Transplantation (2007) 1.56

Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer (2002) 1.52

Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.48

Genetic analysis in Leber's hereditary optic neuropathy using the comparative genomic hybridization technique. Clin Experiment Ophthalmol (2003) 1.45

Oxidative stress, mitochondrial DNA mutation, and apoptosis in aging. Exp Biol Med (Maywood) (2007) 1.45

Surgically curable non-iron deficiency microcytic anemia: Castleman's disease. Onkologie (2011) 1.44

Liver resection for hepatocellular carcinoma in patients who have undergone prior renal transplantation. J Surg Oncol (2006) 1.44

Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients. World J Surg (2015) 1.41

Clinical significance of AXL kinase family in gastric cancer. Anticancer Res (2002) 1.40

Leber's hereditary optic neuropathy: a multifactorial disease. Prog Retin Eye Res (2006) 1.37

Mitochondria and aging. Adv Exp Med Biol (2012) 1.37

Identification of a novel cell cycle regulated gene, HURP, overexpressed in human hepatocellular carcinoma. Oncogene (2003) 1.36

Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut (2006) 1.35

8-hydroxy-2'-deoxyguanosine in leukocyte DNA of spermatic vein as a biomarker of oxidative stress in patients with varicocele. J Urol (2004) 1.34

Oxidative stress response elicited by mitochondrial dysfunction: implication in the pathophysiology of aging. Exp Biol Med (Maywood) (2013) 1.30

Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci (2009) 1.29

Low copy number and low oxidative damage of mitochondrial DNA are associated with tumor progression in lung cancer tissues after neoadjuvant chemotherapy. Interact Cardiovasc Thorac Surg (2008) 1.28

Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metab Dispos (2005) 1.21

Differentiation of apoptosis from necrosis by dynamic changes of reduced nicotinamide adenine dinucleotide fluorescence lifetime in live cells. J Biomed Opt (2008) 1.19

Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Cancer (2012) 1.19

AMPK-mediated increase of glycolysis as an adaptive response to oxidative stress in human cells: implication of the cell survival in mitochondrial diseases. Biochim Biophys Acta (2011) 1.18

Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J Biomed Sci (2002) 1.18

Nutritional factors and survival of patients with oral cancer. Head Neck (2006) 1.17

Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol (2008) 1.17

Relationship between genetic alterations and prognosis in sporadic colorectal cancer. Int J Cancer (2006) 1.16

Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol (2008) 1.14

Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma. Clin Cancer Res (2010) 1.13

Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2006) 1.11

Oxidative stress-induced depolymerization of microtubules and alteration of mitochondrial mass in human cells. Ann N Y Acad Sci (2005) 1.10

Enhanced oxidative stress and aberrant mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells during methamphetamine induced apoptosis. Toxicol Appl Pharmacol (2007) 1.10

Rab5A is associated with axillary lymph node metastasis in breast cancer patients. Cancer Sci (2011) 1.09

Molecular Mechanisms of UV-Induced Apoptosis and Its Effects on Skin Residential Cells: The Implication in UV-Based Phototherapy. Int J Mol Sci (2013) 1.09

Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. Invest Ophthalmol Vis Sci (2006) 1.09

Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Ann Surg (2007) 1.09

Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int J Cancer (2004) 1.07

Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. Carcinogenesis (2012) 1.07

Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog (2011) 1.07

Somatic mutations of mitochondrial DNA in aging and cancer progression. Ageing Res Rev (2010) 1.06

Multiplex amplified product-length polymorphism analysis of 36 mitochondrial single-nucleotide polymorphisms for haplogrouping of East Asian populations. Electrophoresis (2005) 1.06

Protein tyrosine-phosphatase expression profiling in gastric cancer tissues. Cancer Lett (2005) 1.05

The role of mitochondrial DNA alterations in esophageal squamous cell carcinomas. J Thorac Cardiovasc Surg (2009) 1.05

The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer. Stem Cells (2013) 1.05

Rho/Rhotekin-mediated NF-kappaB activation confers resistance to apoptosis. Oncogene (2004) 1.04

Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J (2009) 1.04

Tumor size as a prognostic factor in resected small hepatocellular carcinoma: a controversy revisited. J Gastroenterol Hepatol (2011) 1.03

Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery (2009) 1.03

Mitochondrial bioenergetic function and metabolic plasticity in stem cell differentiation and cellular reprogramming. Biochim Biophys Acta (2011) 1.02

SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett (2009) 1.02

Surgical results of hepatic resection for hepatocellular carcinoma with gross diaphragmatic invasion. Hepatogastroenterology (2005) 1.02

Socio-demographic factors in the prognosis of oral cancer patients. Oral Oncol (2006) 1.02

Increase of oxidative stress in human sperm with lower motility. Fertil Steril (2007) 1.02

Downregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis. Carcinogenesis (2013) 1.02

Association of mitochondrial deoxyribonucleic acid 16189 variant (T->C transition) with metabolic syndrome in Chinese adults. J Clin Endocrinol Metab (2005) 1.02

Mitochondria-mediated caspase-independent apoptosis induced by cadmium in normal human lung cells. J Cell Biochem (2003) 1.01

Response to the increase of oxidative stress and mutation of mitochondrial DNA in aging. Biochim Biophys Acta (2009) 1.00

The model for end-stage liver disease based cancer staging systems are better prognostic models for hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol (2007) 1.00

Long-term results of a randomized, observation-controlled, phase III trial of adjuvant interferon Alfa-2b in hepatocellular carcinoma after curative resection. Ann Surg (2012) 1.00

Mediating of caspase-independent apoptosis by cadmium through the mitochondria-ROS pathway in MRC-5 fibroblasts. J Cell Biochem (2004) 1.00

Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J Biomed Sci (2003) 1.00

Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan. Oncol Rep (2006) 0.99

Synchronous gastric gastrointestinal stromal tumor and signet-ring cell adenocarcinoma: a case report. Int J Surg Pathol (2007) 0.99

Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol (2003) 0.99

Peripheral blood mitochondrial DNA content and dysregulation of glucose metabolism. Diabetes Res Clin Pract (2008) 0.99

Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced β5-integrin expression in human gastric cancer SC-M1 cells. Biochim Biophys Acta (2012) 0.98

Overexpression of protein kinase C alpha mRNA in human hepatocellular carcinoma: a potential marker of disease prognosis. Clin Chim Acta (2007) 0.98

Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application. J Pharm Biomed Anal (2007) 0.98